McKesson Europe AG
CAKFY
Kedudukan dalam Saham
#4398
McKesson Europe AG is a global provider of logistics and a variety of services... McKesson Europe AG is a global provider of logistics and a variety of services to the pharmaceutical and healthcare industries. Its operations are structured into two main segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution arm focuses on the wholesale supply of medicines and other health-related products. It reaches approximately 40,000 pharmacies and hospitals via 90 wholesale branches and manages 70 distribution centers across Europe. Meanwhile, the Retail Pharmacy division oversees roughly 2,000 company-owned pharmacies and collaborates with around 8,000 partners through its brand program. Under the Lloyds Pharmacy brand, this segment also delivers outpatient medication services, e-commerce solutions, and home care, principally in Belgium, Ireland, Italy, and the United Kingdom. Its offerings extend to traditional prescription drugs, over-the-counter (OTC) items, and various medical services. Furthermore, it supports pharmacists by organizing and managing pharmacy cooperation initiatives in Great Britain, France, Portugal, and Belgium. Established in 1835, the company's roots trace back to its former identity, Celesio AG, before rebranding as McKesson Europe AG in September 2017. Headquartered in Stuttgart, Germany, it operates as a subsidiary of McKesson Corporation.
Harga Saham
$4.10
Disegerakkan terakhir: 2023-05-23
Modal Pasaran
$3.49B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
DE
Perdagangan McKesson Europe AG (CAKFY)
Kategori
Healthcare
Nisbah P/E bagi McKesson Europe AG (CAKFY)
Nisbah P/E pada October 2026 TTM: -75.31
Menurut laporan kewangan dan harga saham terkini McKesson Europe AG, nisbah P/E semasa (TTM) ialah -75.31. Pada akhir 2021, syarikat mempunyai nisbah P/E sebanyak 6.01K.
Sejarah nisbah P/E bagi McKesson Europe AG dari 2002 hingga 2026
Nisbah P/E pada akhir setiap tahun
| Tahun | Nisbah P/E | Ubah |
|---|---|---|
| 2026 (TTM) | -75.31 | -18.93% |
| 2022 | -92.90 | -101.54% |
| 2021 | 6.01K | -11,135.56% |
| 2020 | -54.50 | -37.89% |
| 2019 | -87.76 | 399.74% |
| 2018 | -17.56 | 222.97% |
| 2017 | -5.44 | -142.37% |
| 2016 | 12.83 | -88.15% |
| 2014 | 108.29 | 345.94% |
| 2013 | 24.28 | -275.57% |
| 2012 | -13.83 | -104.13% |
| 2011 | 334.62 | 2,755.03% |
| 2010 | 11.72 | -99.09% |
| 2009 | 1.29K | -820.13% |
| 2008 | -179.16 | -1,827.49% |
| 2007 | 10.37 | -12.12% |
| 2006 | 11.80 | -10.76% |
| 2005 | 13.23 | -8.69% |
| 2004 | 14.48 | -29.78% |
| 2003 | 20.63 | -21.38% |
| 2002 | 26.23 | 0.00% |
Nisbah P/E untuk syarikat serupa atau pesaing
| Syarikat | Nisbah P/E | Perbezaan Nisbah P/E | Negara |
|---|---|---|---|
| 26.02 | -134.55% |
US
|
|
| 25.18 | -133.43% |
US
|
|
| 35.41 | -147.02% |
US
|
|
| 13.31 | -117.68% |
US
|
|
| 45.62 | -160.57% |
AU
|
Cara membaca nisbah P/E
Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.
Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.
Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.